Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Prolacta Bioscience Inc.

www.prolacta.com

Latest From Prolacta Bioscience Inc.

Prolacta Formula Fortifier Starts Trial For Newborns With Rare Heart Condition

Prolacta Bioscience developed human milk-based formula fortifier for full-term infants born with conditions that make them vulnerable to nutrition deficiencies. Pending results from research at 12 US hospitals, the product would roll out commercially in 2018.

United States Dietary Supplements

Venture Funding Deals: Takeda Ups Its Bet On Immuno-Oncology Play Maverick

Biscayne and Japanese CRO SNBL create spin-outs to advance programs; liver disease specialist Ascletis gains funds as it shifts away from HCV; Neon gets $100m to put into its cancer vaccines; and other highlights of recent VC funding.

StartUps and SMEs Financing

Industry News Roundup

Disclaimer alert symbol needed in ads; Prestige keeps Dramamine brand; DSM invests in omega-3s; Citizen petition to ban carrageenan withdrawn; NDAC to consider health care antiseptics; and Prolact CR cream supplement helps premature infants.

Consumer Advertising, Marketing & Sales

Industry News Roundup

Disclaimer alert symbol needed in ads; Prestige keeps Dramamine brand; DSM invests in omega-3s; Citizen petition to ban carrageenan withdrawn; NDAC to consider health care antiseptics; and Prolact CR cream supplement helps premature infants.

Consumer Advertising, Marketing & Sales
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Nutraceuticals
  • Therapeutic Areas
  • Gastrointestinal
  • Gynecological, Urological
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Prolacta Bioscience Inc.
  • Senior Management
  • Scott A Elster, CEO
    Tami D Ciranna, CFO
    Victoria Niklas, MD, Chief Medical & Scientific Officer
    Alan Kofsky, VP, Sales & Mktg.
    Martin L Lee, PhD, VP, Clinical Research & Dev.
    Mark Hannon, VP, Operations
  • Contact Info
  • Prolacta Bioscience Inc.
    Phone: (626) 599-9260
    757 Baldwin Park Blvd.
    City of Industry, CA 91746
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register